GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Shouldn't Merrimac be in the news flow?<

Merrimack’s phase-2 results in RA are listed in the calendar on the Biotech Values board as a July event (#msg-26536071). I suppose this could be included in the news flow post in the GTCB ReadMeFirst; the reason I didn’t include it is that I don’t expect these results to be a market-moving event for GTCB.

I’ll update the Merrimack-specific post in the ReadMeFirst to make it current. Regards, Dew